This study is not yet recruiting. It focuses on schizophrenia and currently lists study information in the United States.
This study is looking at whether a digital support tool can help people with depression, psychosis, or bipolarity. Participants take part in a digital support tool and complete follow-up assessments. Some participants may receive usual care instead of the study treatment, and direct benefit is not guaranteed.
The official record suggests in-person participation through a lab, with sites including VA San Diego Healthcare System, San Diego, CA in San Diego, VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, and New Mexico VA Health Care System, Albuquerque, NM in Albuquerque. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it is evaluating Collaborative Decision Skills Training, Leveling Up in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may help test a support approach in real life.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in United States.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring digital app or tool for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with usual care. Direct benefit is not guaranteed.
This study is sponsored by VA Office of Research and Development, a government agency. The VA Office of Research and Development is part of the U.S. Department of Veterans Affairs research program. The sponsor is based in the United States. Sponsor website: https://www.research.va.gov. You can verify the sponsor and study responsibility in the official registry record.
This study may involve digital app or tool, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.